DUSA Pharmaceuticals

From Wikipedia, the free encyclopedia
Jump to: navigation, search

DUSA Pharmaceuticals, Inc., owned by Sun Pharma, is a pharmaceutical company with dermatology products, including Levulan and Nicomide.

In the first quarter of 2006, DUSA Pharmaceuticals obtained Sirius Laboratories in a merger estimated to be worth 30 million dollars. Sirius was a privately held dermatology specialty pharmaceuticals company founded by Dr. Joel E. Bernstein in 2000 dedicated to the treatment of acne vulgaris and acne rosacea.[1]

In 2012, Caraco Pharmaceutical Laboratories (CPL), a subsidiary of Sun Pharmaceutical, acquired DUSA.[2]

External links[edit]

References[edit]

  1. ^ "DUSA Pharmaceuticals Closes Acquisition of Sirius Laboratories". BNET. 2006-04-14. Retrieved 2008-08-26. 
  2. ^ Caraco Pharmaceutical Laboratories Announces Successful Tender Offer To Acquire DUSA. [1] and [2]